Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Invested Capital: 2016-2024

Historic Invested Capital for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $262.9 million.

  • Organogenesis Holdings' Invested Capital fell 10.33% to $255.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $255.1 million, marking a year-over-year decrease of 10.33%. This contributed to the annual value of $262.9 million for FY2024, which is 7.48% down from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Invested Capital is $262.9 million, which was down 7.48% from $284.1 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Invested Capital peaked at $315.4 million during FY2021, and registered a low of $211.8 million during FY2020.
  • In the last 3 years, Organogenesis Holdings' Invested Capital had a median value of $270.2 million in 2022 and averaged $272.4 million.
  • Its Invested Capital has fluctuated over the past 5 years, first spiked by 100.61% in 2020, then decreased by 14.33% in 2022.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Invested Capital stood at $211.8 million in 2020, then surged by 48.91% to $315.4 million in 2021, then dropped by 14.33% to $270.2 million in 2022, then grew by 5.16% to $284.1 million in 2023, then declined by 7.48% to $262.9 million in 2024.